MedTrace Logo

Role of Dairy Products in Weight Maintenance

NCT00686426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2008-05-29

No results posted yet for this study

Summary

The goal of the current study is to determine the role of dairy in similarly preventing weight and fat re-gain in obese adults who have successfully completed a weight loss diet program.240 obese subjects will undergo a meal-replacement-based weight loss plan designed to produce a 10 kg weight loss in 8-12 weeks. Upon achieving the weight loss goal, subjects will be randomly assigned to either a low-dairy or high-dairy eucaloric weight maintenance diet for two years. Macronutrient distribution will be maintained constant and set at approximately the U.S. average. Primary outcomes include changes in body weight, body fat and anatomical distribution of fat (via dual x-ray absorptiometry) and resting metabolic rate and substrate oxidation (via respiratory calorimetry); Secondary outcomes include blood pressure, circulating glucose, insulin, lipids and calcitrophic hormones. on prevention of weight regain in humans has not yet been assessed in clinical trials.

Conditions

Interventions

DIETARY_SUPPLEMENT

Dairy Foods

Adequate dairy (\> 3 standard daily servings)

DIETARY_SUPPLEMENT

Dairy Foods

\< 1 standard dairy serving/day

Sponsors & Collaborators

  • National Dairy Council

    collaborator OTHER

  • University of Kansas

    collaborator OTHER

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Michael B Zemel, PhD · University of Tennessee

  • Joseph E Donnelly, PhD · University of Kansas

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2007-02-28
Completion
2007-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00686426 on ClinicalTrials.gov